Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same

• US 8,374,704 B2
• Filed: 05/21/2010
• Issued: 02/12/2013
• Est. Priority Date: 09/02/2009
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Desai, Shrojalkumar, Boden, Mark W., DeRoche, Steve, Foster, Arthur J., Reddy, Shantanu
• Primary Examiner(s): Seidleck, James J
• Assistant Examiner(s): Salamon, Peter A
• Application Number:
  US12/784,559
• Publication Number:
  US 20110054580A1
• Time in Patent Office: 998 Days
• Field of Search: 607/116, 428/500, 428/523
• US Class Current: 607/116
• CPC Class Codes: A61L 31/06 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L31/041 takes precedence
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems
• CPC Class Codes: C08G 18/4854 Polyethers containing oxyalkylene groups having four carbon atoms in the alkylene group
• CPC Class Codes: C08G 18/698 Mixtures with compounds of group C08G18/40
• CPC Class Codes: C08L 75/02 Polyureas
• CPC Class Codes: C08L 75/04 Polyurethanes
• CPC Class Codes: Y10T 156/10 Methods of surface bonding and/or assembly therefor
• CPC Class Codes: Y10T 428/31855 Of addition polymer from unsaturated monomers
• CPC Class Codes: Y10T 428/31938 Polymer of monoethylenically unsaturated hydrocarbon

Abstract

The present invention provides medical devices that contain polyisobutylene urethane copolymers, polyisobutylene urea copolymers and polyisobutylene urethane/urea copolymers. More particularly, the present invention provides medical leads that contain such copolymers.

Claims

1. An implantable medical lead comprising:

an elongated polymeric component disposed over at least one electrical conductor, wherein the elongated polymeric component comprises a polyisobutylene-based urethane copolymer comprising a polyisobutylene segment and a polyether segment selected from the group consisting of linear, branched and cyclic homopoly(alkylene oxide) and copoly(alkylene oxide) segments, wherein the elongated polymeric component comprises a main lead portion ranging from about 5 cm to about 125 cm in length and having a Shore hardness ranging from about 75 A to about 100 A and a distal tip portion positioned distal to the main lead portion, said distal tip portion ranging from about 1 cm to about 12 cm in length and having a lower Shore hardness than the main lead body ranging from about 30 A to 80 A.

2. The implantable medical lead of claim 1, wherein the polyether segment comprises a poly(methylene oxide) segment.

3. The implantable medical lead of claim 1, wherein the polyether segment comprises a polytetramethylene oxide segment.

4. The implantable medical lead of claim 3, wherein the polyisobutylene-based urethane copolymer comprises between 1 wt % and 30 wt % polytetramethylene oxide segment based on the total weight of the polyisobutylene segment and the polytetramethylene oxide segment.

5. The implantable medical lead of claim 3, wherein the polyisobutylene-based urethane copolymer comprises between 5 wt % and 20 wt % of the polytetramethylene oxide segment based on the total weight of the polyisobutylene segment and the polytetramethylene oxide segment.

6. The implantable medical lead of claim 3, wherein the polyisobutylene segment and the polytetramethylene oxide segment comprise soft segments, a segment comprising a diisocyanate residue comprises a hard segment and the weight ratio of soft segment to hard segment ranges from about 99:

1 to about 50;

50.

7. The implantable medical lead of claim 6, wherein the weight ratio of soft segment to hard segment ranges from about 80:

20 to about 60;

40.

8. The implantable medical lead of claim 1, wherein the main lead body portion has a length from about 40-100 cm and a Shore hardness of between 90 A and 100 A.

9. The implantable medical lead of claim 8, wherein the distal tip has a length from about 1 to about 5 cm and a Shore hardness between 50 A and 70 A.

10. The implantable medical lead of claim 1, wherein the elongated polymeric component further comprises a proximal portion that is positioned proximal to the main lead portion, which ranges from about 10 to about 15 cm in length and has a Shore hardness ranging from about 80 A to less than 98 A.

11. The implantable medical lead of claim 10, wherein the proximal portion has a Shore hardness ranging from about 80 A to about 90 A.

12. The implantable medical lead of claim 10, wherein the elongated polymeric component further comprises an additional portion positioned between the proximal portion and the main lead portion and ranging from about 7.5 to about 12 cm in length and having a Shore hardness ranging from about 70 A to 85 A.

13. A method of manufacturing an implantable medical lead comprising:

forming a main tubular lead body portion from a polyisobutylene-based urethane copolymer comprising a polyisobutylene segment and a polyether segment selected from the group consisting of linear, branched and cyclic homopoly(alkylene oxide) and copoly(alkylene oxide) segments, the main lead body ranging from about 5 cm to about 125 cm in length and having a Shore hardness ranging from about 75 A to about 100 A;

forming a distal tip portion positioned distal to the main lead portion, said distal tip portion ranging from about 1 cm to about 12 cm in length and having a lower Shore hardness that the main lead body portion ranging from about 30 A to about 80 A;

associating at least the main tubular lead body portion with a conductor and an electrode connected to the conductor.

14. The method of claim 13 wherein the distal tip is formed from a copolymer comprising a polyisobutylene segment and a polyether segment selected from the group consisting of linear, branched and cyclic homopoly(alkylene oxide) and copoly(alkylene oxide) segments.

15. The method of claim 13 wherein the polyether segment comprises polytetramethylene oxide.

16. The method of claim 13 wherein at least the main lead body is formed by extrusion.

17. The method of claim 13 wherein the at least the main lead body is formed by extruding a polymer material comprising the polyisobutylene-based urethane copolymer and at least one processing aid.

18. The method of claim 13 wherein the main lead body and distal tip portion are integrally formed by continuous extrusion.

19. The method of claim 13 wherein the main lead body and distal tip portion are separately formed and attached.

20. The method of claim 13 wherein the main lead body is formed from a mixture of a first polymer material and a second polymer material in a first ratio, and the distal tip portion is formed from the first polymer material and the second polymer material in a second ratio.

21. The method of claim 13 wherein the first polymer material and the second polymer material each comprise the polyisobutylene-based urethane copolymer.

22. The method of claim 21 wherein the polyisobutylene-based urethane copolymer of the first polymer material and the second polymer material comprise different weight ratios of soft segment to hard segment.

23. The method of claim 13 further comprising the step of forming a proximal portion from a polyisobutylene-based urethane copolymer comprising a polyisobutylene segment and a polytetramethylene oxide segment, which is positioned proximal to the main lead portion, ranges from about 10 to about 15 cm in length and has a Shore hardness ranging from about 80 A to less than 98 A.

24. The method of claim 23 further comprising the step of forming an additional portion from a polyisobutylene-based urethane copolymer comprising a polyisobutylene segment and a polytetramethylene oxide segment, which is positioned between the proximal and main lead portion, ranges from about 7.5 to about 12 cm in length and has a Shore hardness ranging from about 70 A to 85 A.

25. The method of claim 13 wherein the polyisobutylene segment is formed from a saturated polyisobutylene diol starting material.

26. The method of claim 13 wherein the polyisobutylene segment is formed from a saturated polyisobutylene diol starting material having a number average molecular weight of between about 1000 and 5000.

27. The method of claim 13 wherein the polyether segment comprises polytetramethylene oxide having a number average molecular weight of between about 900 and about 1200.

28. The method of claim 13 wherein the main tubular lead portion has a Shore hardness ranging from 90 A to 100 A and the distal tip has a Shore hardness ranging from 50 A to 70 A.

29. An implantable medical lead comprising an elongated polymeric component comprising:

an elongated polymeric component disposed over at least one electrical conductor, wherein the elongated component comprises a polyisobutylene-based urethane, urea or urethane/urea copolymer comprising a polyisobutylene segment and a polytetramethylene oxide segment, wherein the lead includes at least one spiral loop when in a relaxed state, and wherein the Shore hardness of a surface of the elongated polymeric component that faces radially outward from the center of the spiral loop ranges between about 90 A and about 100 A and the Shore hardness of a surface of the elongated polymeric component that faces radially inward toward a center of the spiral loop ranges between about 50 A and less than 90 A.